Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
33.62
+0.74 (2.25%)
At close: Jun 12, 2026, 4:00 PM EDT
33.75
+0.13 (0.39%)
After-hours: Jun 12, 2026, 7:48 PM EDT
Immunovant Employees
Immunovant had 315 employees as of March 31, 2026. The number of employees decreased by 47 or -12.98% compared to the previous year.
Employees
315
Change (1Y)
-47
Growth (1Y)
-12.98%
Revenue / Employee
n/a
Profits / Employee
-$1,605,098
Market Cap
6.90B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 315 | -47 | -12.98% |
| Mar 31, 2025 | 362 | 155 | 74.88% |
| Mar 31, 2024 | 207 | 43 | 26.22% |
| Mar 31, 2023 | 164 | 40 | 32.26% |
| Mar 31, 2022 | 124 | 56 | 82.35% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Legend Biotech | 2,965 |
| PTC Therapeutics | 991 |
| Vaxcyte | 507 |
| Mirum Pharmaceuticals | 418 |
| TG Therapeutics | 399 |
| Apogee Therapeutics | 261 |
| Kymera Therapeutics | 253 |
| Praxis Precision Medicines | 168 |
IMVT News
- 18 days ago - Immunovant price target raised to $47 from $35 at JPMorgan - TheFly
- 18 days ago - Immunovant price target raised to $62 from $44 at Guggenheim - TheFly
- 22 days ago - Immunovant price target raised to $30 from $23 at Truist - TheFly
- 23 days ago - Immunovant price target raised to $43 from $32 at BofA - TheFly
- 23 days ago - Immunovant price target raised to $40 from $35 at H.C. Wainwright - TheFly
- 24 days ago - Immunovant rises 33.6% - TheFly
- 24 days ago - This Is Why Immunovant Stock (IMVT) Is Up Today - TipRanks
- 24 days ago - 2 Biotech Stocks Are Surging Today Thanks to This Arthritis Drug - Barrons